FDA to hold long-awaited meeting to review off-label marketing
(By Ed Silverman for STAT) After years of anticipation, the US Food and Drug Administration will hold a public, two-day
Read More
California court hangs out a welcome sign: Drug makers can be sued here
(By Ed Silverman for STAT) In a closely watched decision, the California Supreme Court ruled 4-3 Monday that hundreds of
Read MoreAs Parkinson’s patients wait, Fox Foundation and scientist feud over drug trial
(By Charles Piller for STAT) A crucial clinical trial of the most promising new treatment for Parkinson’s disease in decades might
Read MoreAnother Biosimilar Wins FDA Approval
U.S. Food and Drug Administration (FDA) approved Novartis’s Sandoz drug Erelzi (biosimilar copy of Amgen’s Enbrel) on Tuesday but it
Read MoreIn Philadelphia, Neighbors Learn How To Keep Shooting Victims Alive
(By Taunya English for NPR) When a young African-American man dies in the city of Philadelphia, more than half the
Read MoreCardiac Rehab Improves Health, But Cost And Access Issues Complicate Success
(By Julie Appleby for Kaiser Health News) CHARLOTTESVILLE, Va. — Mario Oikonomides credits a massive heart attack when he was 38
Read MoreYour Gut’s Gone Viral, And That Might Be Good For Your Health
(By Michaeleen Doucleff for NPR) Everywhere you turn, it seems, there’s news about the human microbiome. And, more specifically, about
Read MoreMaker Of EpiPen To Sell Generic Version For Half The Price
(By Alison Kodjak for NPR) Treatment for life-threatening allergic reactions is about to get a little cheaper. Mylan, the maker
Read MoreScreening Positive For Depression Doesn’t Mean You’ll Get Treatment, Study Finds
(By Zhai Yun Tan for Kaiser Health News) Getting treatment for depression may sometimes be a regular part of health
Read More‘America’s Other Drug Problem’: Copious Prescriptions For Hospitalized Elderly
(By Anna Gorman for Kaiser Health News) SANTA MONICA, Calif. — Dominick Bailey sat at his computer, scrutinizing the medication lists
Read More